SPRO (STOCKS)
Spero Therapeutics, Inc. Common Stock
$2.387000
+0.027000 (+1.14%)
Prev close: $2.360000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Esther Rajavelu
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $134.09M
- Employees
- 32
- P/E (TTM)
- -2.97
- P/B (TTM)
- 5.02
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
3
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.13 | $-0.26 | +0.1250 | +49.02% |
|
Jun 2025 (Q2)
|
$-0.03 | $-0.39 | +0.3576 | +92.26% |
|
Mar 2025 (Q1)
|
$-0.25 | $-0.56 | +0.3110 | +55.44% |
|
Dec 2024 (Q4)
|
$-0.38 | $-0.32 | -0.0638 | -20.18% |
Financial Statements
| Revenues | $13.51M |
| Benefits Costs and Expenses | $13.00M |
| Cost Of Revenue | $5.70M |
| Costs And Expenses | $13.00M |
| Gross Profit | $7.81M |
| Operating Expenses | $7.31M |
| Selling, General, and Administrative Expenses | $6.19M |
| Other Operating Expenses | $1.12M |
| Operating Income/Loss | $498.50K |
| Income/Loss From Continuing Operations After Tax | $161.59K |
| Income/Loss From Continuing Operations Before Tax | $515.43K |
| Income/Loss From Discontinued Operations Net Of Tax | -$687.54K |
| Income/Loss From Equity Method Investments | $1.20K |
| Income Tax Expense/Benefit | $353.84K |
| Net Income/Loss | -$525.95K |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$525.95K |
| Net Income/Loss Available To Common Stockholders, Basic | -$525.95K |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Average Shares | 13,780,944 |
| Diluted Average Shares | 13,795,828 |
| Assets | $11.80M |
| Current Assets | $5.70M |
| Noncurrent Assets | $6.10M |
| Fixed Assets | $423.32K |
| Intangible Assets | $2.92M |
| Other Non-current Assets | $2.75M |
| Liabilities | $4.48M |
| Current Liabilities | $4.42M |
| Accounts Payable | $325.78K |
| Other Current Liabilities | $4.09M |
| Noncurrent Liabilities | $61.41K |
| Equity | $7.32M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $7.32M |
| Liabilities And Equity | $11.80M |
| Net Cash Flow From Operating Activities | $1.30M |
| Net Cash Flow From Operating Activities, Continuing | $1.30M |
| Net Cash Flow From Investing Activities | -$488.81K |
| Net Cash Flow From Investing Activities, Continuing | -$488.81K |
| Net Cash Flow From Financing Activities | -$415.84K |
| Net Cash Flow From Financing Activities, Continuing | -$415.84K |
| Net Cash Flow | $398.88K |
| Net Cash Flow, Continuing | $398.88K |
| Comprehensive Income/Loss | -$525.95K |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$525.95K |
| Other Comprehensive Income/Loss | $0.00 |